PMID- 31005338 OWN - NLM STAT- MEDLINE DCOM- 20191220 LR - 20200701 IS - 1532-818X (Electronic) IS - 0196-0709 (Print) IS - 0196-0709 (Linking) VI - 40 IP - 4 DP - 2019 Jul-Aug TI - Clinical practice patterns in laryngeal cancer and introduction of CT lung screening. PG - 520-524 LID - S0196-0709(19)30311-4 [pii] LID - 10.1016/j.amjoto.2019.04.010 [doi] AB - OBJECTIVES: After the publication of large clinical trials, in January 2014 The U.S. Preventive Services Task Force (USPSTF) recommended annual lung cancer screening with low-dose CT in a well-defined group of high-risk smokers. A significant proportion of patients with laryngeal cancer (LC) meet the introduced criteria, and we hypothesized that clinical practice would change as a result of these evidence-based guidelines. METHODS: Retrospective chart review of patients diagnosed with LC and treated at Johns Hopkins Hospital who met USPSTF criteria for annual chest screening and were followed for at least 3 consecutive years in the years surrounding the introduction of screening guidelines (January 2010 to December 2017) was performed to identify those who had recommended screening CT chest. RESULTS: A total of 151 patients met the inclusion criteria of the study and were followed for a total of 746 patient-years. 184/332 (55%) patient-years in the pre-guidelines period and 246/414 (59%) in the post-guidelines period included at least one recommended chest imaging (CT or PET-CT; p = 0.27). 248/332 (75%) patient-years in the pre-guidelines period and 314/414 (76%) in the post-guidelines period included any radiological chest imaging (X-ray, CT or PET-CT; p = 0.72). Screening scans were ordered by OHNS (45%), Medical Oncology (31%), Radiation Oncology (8%), and primary care (14%) with 70% of patients missing at least one year of indicated screening. CONCLUSIONS: The implementation of new lung cancer screening guidelines did not change clinical practice in the management of patients with LC and many patients do not receive recommended screening. Further study concerning potential barriers to effective evidence-based screening and coordination of care is warranted. CI - Copyright (c) 2019 Elsevier Inc. All rights reserved. FAU - Piersiala, Krzysztof AU - Piersiala K AD - Department of Otolaryngology - Head and Neck Surgery, Johns Hopkins University, Baltimore, MD, United States of America; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institute, Stockholm, Sweden. FAU - Akst, Lee M AU - Akst LM AD - Department of Otolaryngology - Head and Neck Surgery, Johns Hopkins University, Baltimore, MD, United States of America. FAU - Hillel, Alexander T AU - Hillel AT AD - Department of Otolaryngology - Head and Neck Surgery, Johns Hopkins University, Baltimore, MD, United States of America. FAU - Best, Simon R AU - Best SR AD - Department of Otolaryngology - Head and Neck Surgery, Johns Hopkins University, Baltimore, MD, United States of America. Electronic address: Sbest2@jhmi.edu. LA - eng GR - K23 DC014758/DC/NIDCD NIH HHS/United States GR - L40 DC013350/DC/NIDCD NIH HHS/United States PT - Journal Article DEP - 20190412 PL - United States TA - Am J Otolaryngol JT - American journal of otolaryngology JID - 8000029 SB - IM MH - Aged MH - Aged, 80 and over MH - Evidence-Based Practice MH - Female MH - Humans MH - Laryngeal Neoplasms/*diagnostic imaging/*prevention & control MH - Lung Neoplasms/*diagnostic imaging/*prevention & control MH - Male MH - *Mass Screening MH - Middle Aged MH - Positron Emission Tomography Computed Tomography MH - Practice Guidelines as Topic MH - *Practice Patterns, Physicians' MH - Smokers MH - Tomography, X-Ray Computed PMC - PMC6570546 MID - NIHMS1527590 OTO - NOTNLM OT - CT OT - Head and neck cancer OT - Laryngeal cancer OT - Lung cancer OT - Lung cancer screening COIS- Conflict of Interest: None of the authors have any conflicts of interest or financial ties to disclose. The authors whose names are listed immediately above certify that they have NO affiliations or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript. EDAT- 2019/04/22 06:00 MHDA- 2019/12/21 06:00 PMCR- 2020/07/01 CRDT- 2019/04/22 06:00 PHST- 2019/04/08 00:00 [received] PHST- 2019/04/12 00:00 [accepted] PHST- 2019/04/22 06:00 [pubmed] PHST- 2019/12/21 06:00 [medline] PHST- 2019/04/22 06:00 [entrez] PHST- 2020/07/01 00:00 [pmc-release] AID - S0196-0709(19)30311-4 [pii] AID - 10.1016/j.amjoto.2019.04.010 [doi] PST - ppublish SO - Am J Otolaryngol. 2019 Jul-Aug;40(4):520-524. doi: 10.1016/j.amjoto.2019.04.010. Epub 2019 Apr 12.